Malak Alharbi

Jeddah, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

HSR26-254: Comparative Survival in Elderly (≥70 Years) Stage II and Stage III Colon Cancer Patients Treated With Adjuvant CAPOX/FOLFOX Versus 5-FU/Capecitabine: A Real-World Analysis Using TriNetX.

HSR26-254: Comparative Survival in Elderly (≥70 Years) Stage II and Stage III Colon Cancer Patients Treated With Adjuvant CAPOX/FOLFOX Versus 5-FU/Capecitabine: A Real-World Analysis Using TriNetX.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 16, 2026

HSR26-254: Comparative Survival in Elderly (≥70 Years) Stage II and Stage III Colon Cancer Patients Treated With Adjuvant CAPOX/FOLFOX Versus 5-FU/Capecitabine: A Real-World Analysis Using TriNetX.

HSR26-254: Comparative Survival in Elderly (≥70 Years) Stage II and Stage III Colon Cancer Patients Treated With Adjuvant CAPOX/FOLFOX Versus 5-FU/Capecitabine: A Real-World Analysis Using TriNetX.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 31, 2026

Racial and ethnic disparities in clinical outcomes of HER2-positive metastatic breast cancer treated with antibody-drug conjugates.

Racial and ethnic disparities in clinical outcomes of HER2-positive metastatic breast cancer treated with antibody-drug conjugates.

Journal: Journal of the National Cancer Institute

Published: February 28, 2026

Effects of Neighborhood Deprivation Index on Survival in Gastroesophageal Adenocarcinoma.

Effects of Neighborhood Deprivation Index on Survival in Gastroesophageal Adenocarcinoma.

Journal: Healthcare (Basel, Switzerland)

Published: July 02, 2025

Association and Prognostic Significance of Comorbidities in Individuals With MGUS.

Association and Prognostic Significance of Comorbidities in Individuals With MGUS.

Journal: Clinical lymphoma, myeloma & leukemia

Published: May 14, 2025

Clinical Characteristics and Survival Trends of Male Breast Cancer in the United States: A Propensity Score Matched Analysis.

Clinical Characteristics and Survival Trends of Male Breast Cancer in the United States: A Propensity Score Matched Analysis.

Journal: Journal of personalized medicine

Published: May 06, 2025

HSR25-170: Investigating Socioeconomic and Racial Disparities in Pathologic Response and Survival Outcomes in Triple-Negative Breast Cancer Post-Neoadjuvant Chemotherapy: Insights From the National Cancer Database.

HSR25-170: Investigating Socioeconomic and Racial Disparities in Pathologic Response and Survival Outcomes in Triple-Negative Breast Cancer Post-Neoadjuvant Chemotherapy: Insights From the National Cancer Database.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 28, 2025

Area deprivation index and breast cancer outcomes among patients in Western New York.

Area deprivation index and breast cancer outcomes among patients in Western New York.

Journal: Breast cancer research and treatment

Published: February 18, 2025

Rare case of pure red cell aplasia secondary to smoldering multiple myeloma successfully treated with daratumumab - case report and review of the literature.

Rare case of pure red cell aplasia secondary to smoldering multiple myeloma successfully treated with daratumumab - case report and review of the literature.

Journal: Annals of hematology

Published: November 26, 2024

Detrimental Impact of Chemotherapy Dose Reduction or Discontinuation in Early Stage Triple-Negative Breast Cancer Treated With Pembrolizumab and Neoadjuvant Chemotherapy: A Multicenter Experience.

Detrimental Impact of Chemotherapy Dose Reduction or Discontinuation in Early Stage Triple-Negative Breast Cancer Treated With Pembrolizumab and Neoadjuvant Chemotherapy: A Multicenter Experience.

Journal: Clinical breast cancer

Published: May 26, 2024

Breast biomarkers evolution between primary and distant metastasis: incidence and significance.

Breast biomarkers evolution between primary and distant metastasis: incidence and significance.

Journal: Histopathology

Published: May 21, 2024

Targeting the tumor microenvironment to improve clinical outcomes in triple negative breast cancer patients and bridge the current disparity gap.

Targeting the tumor microenvironment to improve clinical outcomes in triple negative breast cancer patients and bridge the current disparity gap.

Journal: Frontiers in immunology

Published: May 05, 2024

Showing 1-12 of 13

Last Updated: 09/26/2026